Presentations

The following are selected presentations of ABS Team Members:

2009

Burton T, Boulanger L, Larholt K, Pashos C, McKenzie RS, Senbetta M, Lopez J, Sundaresan D, Preusse P, Seidler C. Blood and resource utilization in cancer patients with chemotherapy-induced anemia (CIA) in the pre- and post-national coverage determination (NCD) timeframes: Results from an electronic medical record study. American Society of Hematology, 51st Annual Meeting and Exposition, New Orleans, LA, December 5-8, 2009.

Apgar E, Burton TM, Larholt K, Pashos CL, Ellis L, Senbetta M, McKenzie RS. Hematologic and hospitalization outcomes in patients with chemotherapy-induced anemia (CIA) treated with erythropoiesis-stimulating agents (ESAs) in the pre- vs post-national coverage determination (NCD) time periods. American Society of Hematology, 51st Annual Meeting and Exposition, New Orleans, LA, December 5-8, 2009.

Schiff L, Foster T, Junker F, Vogel-Ziebolz S, Pashos CL, Creeden J. Development of serum tests for colorectal cancer screening. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual European Congress, Paris, France, October 24-27, 2009.

Hadker N, Garg S, Costanzo C, Miller JD, van der Helm W, Foster T, Creeden J. Financial impact of a novel preeclampsia diagnostic test vs. standard care: a decision-analytic modeling analysis from a German health care payer perspective. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual European Congress, Paris, France, October 24-27, 2009.

Hadker N, Garg S, Costanzo C, Miller JD, van der Helm W, Foster T, Creeden J. Financial impact of a novel preeclampsia diagnostic test vs. standard care: a decision-analytic modeling analysis from a UK health care payer perspective. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual European Congress, Paris, France, October 24-27, 2009.

Chen SY, Boulanger L, Fraser K, Wu N, Zhao Y. Adherence to duloxetine therapy and health care costs among patients with fibromyalgia. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual

Wu N, Chen SY, Fraser K, Boulanger L, Zhao Y. Treating fibromyalgia with duloxetine: what is the association between average daily dose, medication adherence, and healthcare costs? International Society for Pharmacoeconomics and Outcomes Research, 12th Annual European Congress, Paris, France, October 24-27, 2009.

Zhao Y, Chen SY, Boulanger L, Fraser K, Wu N. Time to opioid use and health care costs among patients with diabetic peripheral neuropathic pain who initiated duloxetine versus other treatments. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual European Congress, Paris, France, October 24-27, 2009.

Svedsater H, Harrow B, Wu N, Ozer-Stillman I, Locklear JC. Mental health costs incurred by patients diagnosed with major depressive disorder who do not respond to successive lines of treatment. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual European Congress, Paris, France, October 24-27, 2009.

Lee WC, Ma L, Harrow B, Wu N, Menditto L, Arondekar B. Resource utilization (RU) and costs associated with use of add-on therapy with rosiglitazone (RSG) vs. Sulfonylurea (SU) to metformin (MET) monotherapy. American Diabetes Association, 69th Scientific Sessions, New Orleans, LA, June 5-9, 2009.

Ganz M. Methods for interpreting and displaying results from regression models: beyond betas and odds ratios. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Burton T, Larholt K, Apgar E, Pashos CL, McKenzie RS, Piech CT. Clinical and economic outcomes in cancer chemotherapy patients initiated on erythropoiesis stimulating agents (ESA) at hemoglobin (HB) levels <10 g/dl. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Foster T, Miller JD, Boye ME, Blieden MB, Ancukiewicz V, Russell MW. The economic burden of metastatic breast cancer. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

De Leon MC, Mody R, Boulanger L. Examining proton pump inhibitor (PPI) treatment patterns among patients with selected upper gastrointestinal conditions. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Schiff L, Foster T, Creeden J, Gartemann J, Hsieh J, Pashos CL. Development of tests for diagnosis of rheumatoid arthritis. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Denevich S, Lee WC, Waycaster C, Pennie S, Ganz M, Pashos CL. Outcomes of cataract patients with astigmatism: implantation of toric versus conventional monofocal intraocular lens. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Caloyeras JP, Harrow B, Wang C, Beckmann K, Knappertz V, Pohl C, Miller JD, Russell MW, Sandbrink R, Gondek K. Cost-utility of interferon beta-b in the treatment of patients with a clinically isolated syndrome suggestive of multiple sclerosis: model utilizing five year benefit data. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Boulanger L, Kongsø JH, Bouchard JR, Christensen T, Fraser K, Russell MW. Excess costs of diabetes mellitus among medicare recipients in a skilled nursing facility setting. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Boulanger L, Wu N, Chen SY, Fraser K, Zhao Y. Changes in opioid use and economic outcomes among diabetic peripheral neuropathic pain patients treated with duloxetine. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Wu N, Zhao Y, Boulanger L, Fraser K, Chen SY. Duloxetine therapy and changes in opioid use among diabetic peripheral neuropathic pain patients. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Smalarz A, Lee WC, Pashos CL, Pennie S, Wittrup-Jensen K. Acute care costs of gram-negative pneumonia in the United States: a healthcare cost and utilization project (HCUP) data analysis. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Schiff L, Foster T, Creeden J, Van der Helm W, Gartemann J, Pashos CL. Development of tests for early diagnosis of preeclampsia. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Smalarz AM, Denevich S, Boulanger L, Spalding J. Increased patient throughput and reduction in laboratory staff and labor intensity with the use of regadenoson. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Smalarz AM, Harrow B, Schoeman O, Uhl-Hochgraeber K, Pashos CL. Cost of pseudomonas aeruginosa in cystic fibrosis patients in the United Kingdom. International Society for Pharmacoeconomics and Outcomes Research, 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Wu N , Zhao Y , Boulanger L. The use of prescribed pain medication prior to the initiation of Duloxetine therapy. American Pain Society, 28th Annual Scientific Meeting, San Diego, CA, May 7-9, 2009.

Wu N , Boulanger L, Fraser K , Zhao Y. Opioid use among patients with diabetic peripheral neuropathic pain following initiation of Duloxetine versus other standard DPNP therapy. American Pain Society, 28th Annual Scientific Meeting, San Diego, CA, May 7-9, 2009.

Zhao Y, Boulanger L, Fraser K, Wu N. Time to opioid use among patients with diabetic peripheral neuropathic pain who initiated Duloxetine versus other treatments. American Academy of Neurology, Annual Meeting, Seattle, WA, April 25–May 2, 2009.

2008

Miller JD, Denevich S, McGarry MJ, Albano MP, Caloyeras JP, Russell MW. Modeling the fiscal impact of using perflutren lipid microspheres (PLM) for follow-up echocardiographic imaging. International Society for Pharmacoeconomics and Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008.

Ganz ML, Prasad M, Yeh YC, Miller JD, Russell MW. Initial combination therapy with infliximab versus sequential DMARD monotherapy: a cost-effectiveness model based on the BeST study. International Society for Pharmacoeconomics and Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008.

Ganz ML, Smalarz AM, Anger JT, Krupski TL, Hu JC, Wittrup-Jensen KU, Pashos CL. Cost of overactive bladder in the United States. International Society for Pharmacoeconomics and Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008.

Zhao Y, Boulanger L, Wu N, Lamothe K, Russell MW. Healthcare resource use and costs among patients with diabetic neuropathic pain in the one-year following duloxetine therapy: is initial dosing a significant factor? International Society for Pharmacoeconomics and Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008.

Brown TM, Lee WC, Joshi AV, Pashos CL. Health-related quality of life and productivity among hemophilia patients with inhibitors. International Society for Pharmacoeconomics and Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008.

Larholt K, Burton T, Boulanger L, et al. Transfusion outcomes in erythropoiesis-stimulating agent (ESA)-treated cancer chemotherapy patients based on achieved hemoglobin (Hb) levels. American Society of Clinical Oncology, 44th Annual Meeting, Chicago, IL, May 30-June 3, 2008.

Ganz ML, Pashos CL, Joshi AV, Wang Q, Lee WC, Wilke CT. Clinical and economic outcomes associated with bleeding during coronary artery bypass graft surgery among elderly Americans. International Society for Pharmacoeconomics and Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.

Lee WC, Brown M, Joshi AV, Foster T, Pashos CL. Patient- and caregiver-reported preferences for characteristics of treatments for hemophilia. International Society for Pharmacoeconomics and Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.

Lee WC, Brown M, Joshi AV, Foster T, Pashos CL. Health-related quality of life of patients with hemophilia and inhibitors. International Society for Pharmacoeconomics and Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.

Gao X, Shah S, Reddy P, Gondek K, Pashos CL. Economic evaluation of sorafenib versus best supportive care in advanced renal cell carcinoma: an updated cost-effectiveness analysis. International Society for Pharmacoeconomics and Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.

Boulanger L, Doan J, Pashos CL. Substance abuse among patients diagnosed with insomnia. International Society for Pharmacoeconomics and Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.

Boulanger L, Mody R, Bao Y, Ancukiewicz V, Kothari-Talwar S, Russell MW. Does the dosing frequency of proton pump inhibitors (PPIs) affect subsequent resource utilization and costs among patients diagnosed with gastroesophageal reflux disease (GERD)? International Society for Pharmacoeconomics and Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.

Lee WC, Pickard S, Wilke C, Joshi AV, Yeh YC, Wang Q, Pashos CL. Economic impact of stroke-related comorbid conditions on the treatment of stroke: an analysis of Medicare beneficiaries in the United States. International Society for Pharmacoeconomics and Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.

Gao X, Spalding JR, Denevich S, Reddy P. Gender disparities in the utilization of myocardial perfusion imaging. International Society for Pharmacoeconomics and Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.

Boulanger L, Zhao Y, Bao Y, Cai C, Ye W, Russell, MW. Factors associated with healthcare costs among elderly patients with diabetic neuropathy. International Society for Pharmacoeconomics and Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.

Caloyeras JP, Wang C, Bauer L, Lee WC, Lanius V, Gondek K. Cost-utility of Interferon Beta-1b in the treatment of patients with a clinically isolated syndrome suggestive of multiple sclerosis. International Society for Pharmacoeconomics and Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.

Larholt K et al. Transfusion outcomes among oncology patients initiated with Erythropoiesis-Stimulating Agents (ESAs) at baseline hemoglobin (Hb) of <10 v 10- 11 g/dL: Observational data from the Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) Registry. Community Oncology Conference, Washington, DC, February 1-3, 2008.

Larholt K et al. Hemoglobin (Hb) levels prior to blood transfusions in oncology patients receiving chemotherapy and Erythropoiesis-Stimulating Agents (ESAs): Observational Data from the Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) Registry. Community Oncology Conference, Washington, DC, February 1-3, 2008.

back to top

2007

Balu S, Dutcher S, Lee WC, Joshi AV, Bilde L, Booth F, Pashos CL. Characterization, risk factors, clinical outcomes, and economic consequences of bleeding associated with cardiac surgery: A systematic literature review. International Society for Pharmacoeconomics and Outcomes Research, 10th Annual European Congress, Dublin, Ireland, October 20-23, 2007.

Lee WC, Joshi AV, Pashos CL. Best-worst case scaling in discrete choice experiments: An application in a rare disease population. International Society for Pharmacoeconomics and Outcomes Research, 10th Annual European Congress, Dublin, Ireland, October 20-23, 2007.

Balu S, Lee WC, Arondekar B, Horblyuk R, Pashos CL. Economic analysis of add-on therapy with thiazolidinedione (TZD) versus insulin (INS) to metformin (MET) monotherapy. American Diabetes Association, 67th Scientific Sessions, Chicago, IL, June 22-26, 2007.

Balu S, Arondekar B, Lee WC, Horblyuk R, Pashos CL. Budgetary impact of thiazolidinedione (TZD) add-on therapy relative to insulin (INS) add-on therapy in individuals treated with sulfonylureas (SU): A third party payer's perspective. American Diabetes Association, 67th Scientific Sessions, Chicago, IL, June 22-26, 2007.

Pashos CL, Wang Q, Larholt K, Bookhart B, McKenzie RS, Piech CT. Drug cost considerations for erythroprietic stimulating therapies (ESTs) agents in patients initiated at FDA-approved dosing: Results from practice patterns in a prospective observational study. Hematology Oncology Pharmacy Association (HOPA), 3rd Annual Conference, Denver, CO, June 14-16, 2007.

Cai QC, Sullivan P, Yeh YC, Russell M. Assessing 12 or more lymph nodes increases the proportion of stage III disease in colorectal cancer (CRC): Evidence from the Surveillance, Epidemiology and End Results (SEER) cancer registry. American Society of Clinical Oncology, 43rd Annual Meeting, Chicago, IL, June 1-5, 2007.

Yeh YC, Cai QC, Chao J, Russell MW. Is more aggressive lymph node assessment associated with improved survival in stage II-III colorectal cancer? Evidence from the Surveillance, Epidemiology and End Results (SEER) cancer registry. American Society of Clinical Oncology, 43rd Annual Meeting, Chicago, IL, June 1-5, 2007.

Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Co-payment level and medication adherence in type 2 diabetes patients managed with insulin aspart pen therapy. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007.

Balu S, Lee WC, Cobden D, Joshi AV, Pashos CL. Impact of initiating or converting to treatment with an insulin aspart analog pen on medication adherence in type 2 diabetes patients on vial/syringe insulin. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007.

Balu S, Dutcher S, Lee WC, Cobden D, Joshi AV, Pashos CL. Epidemiology and economic burden of stroke-related risk factors: A systematic literature review. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007.

Boulanger L, Miller JD, MacEachern L, Reddy P, Russell MW, Pashos CL. Prevalance of cachexia (wasting syndrome) diagnosis and treatment among patients with HIV/AIDS: A medical claims database analysis. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007.

Pashos CL, Wang Q, Larholt K, Bookhart B, McKenzie RS, Piech CT. Drug cost considerations for erythroprietic stimulating therapies (ESTs) agents in patients initiated at FDA-approved dosing: Results from practice patterns in a prospective observational study. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007.

Boulanger L, Brown JS. Methodological considerations in conducting cost of illness studies employing large administrative claim databases. International Society for Pharmacoeconomics and Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007.

Lee WC, Yeh YC, Atzinger C, Pashos CL. Clinical and economic impact of increased colonoscopy screening in the United States: A computer simulation of a Markov process. Digestive Disease Week, Annual Meeting, Washington, DC, May 19-24, 2007.

Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Medication adherence and the health economic impact of anti-diabetic therapy conversion to an insulin analog pen device among type 2 diabetes patients. Academy of Managed Care Pharmacy, 19th Annual Meeting, San Diego, CA, April 11-14, 2007.

back to top

2006

Chen E, Peake C, Buscaino E, Forlenza J, Bookhart B, McKenzie S. Hematologic outcomes and erythropoiesis-stimulating therapy costs in Epoetin Alfa (EPO) and Darbepoetin Alfa (DARB)-treated cancer patients: Results of the Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) Registry. American Society of Hematology, 48th Annual Meeting and Exposition, Orlando, FL, December 9-12, 2006.

Wang Q, Larholt K, Pashos C, Forlenza J, Bookhart B, McKenzie S. Early hemoglobin response to erythropoiesis-stimulating therapies (ESTs) and outcomes in cancer patients with anemia: Results from a prospective, observational study. American Society of Hematology, 48th Annual Meeting and Exposition, Orlando, FL, December 9-12, 2006.

Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Improving medication adherence for type 2 diabetes patients: Effects of an analog insulin pen device. International Diabetes Federation, 19th Annual Meeting, Capetown, South Africa, December 3-7, 2006.

Lee WC, Cobden D, Balu S, Joshi AV, Pashos CL. Reducing hypoglycemic events, costs and associated resource utilization in type 2 diabetes patients with conversion to an analog insulin pen device. Diabetes Technology Society, 6th Annual Meeting, Atlanta, GA, November 2-4, 2006.

Lee WC, Cobden D, Balu S, Joshi AV, Pashos CL. Insulin administration with an analog pen device: Effect on medication adherence in type 2 diabetes patients. Diabetes Technology Society, 6th Annual Meeting, Atlanta, GA, November 2-4, 2006.

Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Insulin therapy among type 2 diabetes patients: Impact of conversion to a pen device on adherence, hypoglycemic events, and costs. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006.

Reddy P, Boci K, Charbonneau C. The epidemiologic, health-related quality of life, and economic burden of gastrointestinal stromal tumors. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006.

Banks J, Gupta K, Balu S, Chen E, Komatsuzaki Y, Charbonneau, Pashos CL. The epidemiologic, humanistic and economic burden of patients with metastatic renal cell carcinoma. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006.

Lee WC, Joshi AV, Brown M, Hadker N, Sumner M, Pashos CL. Physicians’ preferences toward coagulation factor concentrates in the treatment of hemophilia patients with inhibitors: A discrete choice experiment. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006.

Balu S, Lee WC, Joshi AV, Cobden D, Pashos CL. Treatment duration for atrophic vaginitis: Clinical trials versus “the real world”. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006.

Balu S, Lee WC, Joshi AV, Cobden D, Pashos CL. Underutilization of vaginal estrogen therapy in a managed care setting. North American Menopause Society, 17th Annual Meeting, Nashville, TN, October 11-14, 2006.

Lee WC, Wang Q, Balu S, Joshi AV, Cobden D, Pashos CL. Treatment duration and adherence to vaginal estrogen therapy in patients receiving vaginal tablets versus vaginal creams in a managed care setting. North American Menopause Society, 17th Annual Meeting, Nashville, TN, October 11-14, 2006.

Gao X, Sato R, Nab H, Singh A. Cost-effectiveness of TNF inhibitors in the treatment of rheumatoid arthritis using radiographic progression as the effectiveness measure in the Netherlands. European Congress of Rheumatology, Annual Meeting, Amsterdam, Netherlands, June 21-24, 2006.

Gao X, Reddy P, Dhanda R, Gondek K, Yeh YC, Stadler W, Jonasch E. Cost-effectiveness of sorafenib versus best supportive care in advanced renal cell carcinoma. American Society of Clinical Oncology, Annual Meeting, Atlanta, GA, June 2-6, 2006.

Memisoglu A, Peake C, Buscaino E. Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (D.O.S.E.) Registry: Analysis of outcomes and costs of epoetin alfa (EPO) and darbepoetin alfa (DARB) treatment in cancer patients. American Society of Clinical Oncology, Annual Meeting, Atlanta, GA, June 2-6, 2006.

Anger JT, Litwin, MS, Wang Q, Chen E, Pashos CL, Rodríguez LV. Racial disparities in the surgical management of stress incontinence among female Medicare beneficiaries. American Urological Association, Annual Meeting, Atlanta, GA, May 20-25, 2006.

Anger JT, Rodríguez LV, Wang Q, Pashos CL, Litwin MS. High volume providers perform more prolapse repairs at the time of sling surgery. American Urological Association, Annual Meeting, Atlanta, GA, May 20-25, 2006.

Anger JT, Litwin MS, Wang Q, Pashos CL, Rodríguez LV. Complications of sling surgery among female Medicare beneficiaries. American Urological Association, Annual Meeting, Atlanta, GA, May 20-25, 2006.

Anger JT, Litwin MS, Wang Q, Pashos CL, Rodríguez LV. Variations in stress incontinence and prolapse management by surgeon specialty. American Urological Association, Annual Meeting, Atlanta, GA, May 20-25, 2006.

Lee WC, Balu S, Cobden D, Joshi, AV, Pashos CL. A systematic review of adherence with diabetes treatment and impact of non-adherence on healthcare costs. International Society for Pharmacoeconomics and Outcomes Research, 11th Annual International Meeting, Philadelphia, PA, May 20-24, 2006.

Balu S, Cobden D. Joshi AV, Lee WC, Pashos CL. A systematic review of atrophic vaginitis treatment, duration of therapy, and healthcare costs. International Society for Pharmacoeconomics and Outcomes Research, 11th Annual International Meeting, Philadelphia, PA, May 20-24, 2006.

Chavez Y, Atzinger C, Lee WC, Pashos CL. Gaps in the economic evaluation of prostate cancer. International Society for Pharmacoeconomics and Outcomes Research, 11th Annual International Meeting, Philadelphia, PA, May 20-24, 2006.

Gao X, Outley JK, Botteman M, Spalding J, Simon JA, Pashos CL. The economic burden of endometriosis. American College of Obstetrics and Gynecology, Annual Meeting, Washington, DC, May 6-10, 2006.

Anger JT, Rodríguez LV, Wang Q, Pashos CL, Litwin MS. High volume providers perform more prolapse repairs at the time of sling surgery. Society for Urodynamics and Female Urology, International Society of Pelvic Neuromodulation, Genito-Urinary Reconstructive Surgery Society, Geriatric Urologic Society, and International Continence Society, Joint Annual Meeting, Grand Bahama Island, The Bahamas, February 22-25, 2006.

Anger JT, Litwin MS, Wang Q, Pashos CL, Rodríguez LV. Complications of sling surgery among female Medicare beneficiaries. Society for Urodynamics and Female Urology, International Society of Pelvic Neuromodulation, Genito-Urinary Reconstructive Surgery Society, Geriatric Urologic Society, and International Continence Society, Joint Annual Meeting, Grand Bahama Island, The Bahamas, February 22-25, 2006.

Anger JT, Litwin MS, Wang Q, Pashos CL, Rodríguez LV. Variations in stress incontinence and prolapse management by surgeon specialty. Society for Urodynamics and Female Urology, International Society of Pelvic Neuromodulation, Genito-Urinary Reconstructive Surgery Society, Geriatric Urologic Society, and International Continence Society, Joint Annual Meeting, Grand Bahama Island, The Bahamas, February 22-25, 2006.

back to top

2005

Cobden D, Nicklasson L, Pashos C, Lee WC, Conway D. Economic analysis of the direct and indirect post-exposure burden associated with needlestick injury in nurses treating patients with diabetes mellitus. American Society of Health-System Pharmacists, 40th Mid-year Clinical Meeting, Las Vegas, NV, December 4-8, 2005.

Lee WC, Hoffman MS, Arcona S, D’Souza J, Wang Q, Pashos CL. Cost of treatment for patients with partial seizure disorder who are refractory. American Epilepsy Association, 59th Annual Meeting, Washington, DC, December 2-6, 2005.

Lee WC, Memisoglu A, Pashos CL. Challenges of designing prospective and retrospective compliance studies. International Society for Pharmacoeconomics and Outcomes Research, 8th Annual European Congress, Florence, Italy, November 6-8, 2005.

Lee WC, Christensen MC, Joshi AV, Wang Q, Pashos CL. Long-term survival among Medicare beneficiaries with intracranial hemorrhage. 18th World Congress of Neurology, Sydney, Australia, November 5-11, 2005.

Yeh Y, Schaefer C, Kutikova L, Edgell E, Husbands C, Szende A. Quality of life in hepatocellular carcinoma: A review of instruments, disease burden, and quality of life outcomes. International Society for Quality of Life Research (ISOQOL), Annual Meeting, San Francisco, CA, October 19-22, 2005.

Duff S, Yeh Y, Yu E, Woolley J. The economic impact of etanercept and infliximab treatment in ankylosing spondylitis. European Congress of Rheumatology, Annual Meeting, Vienna, Austria, June 8-11, 2005.

Lee WC. Cost of therapy for ARV naïve HIV-infected patients: Fosamprenavir/Ritonavir versus Nelfinavir. International Society for Pharmacoeconomics and Outcomes Research, 10th Annual International Meeting, Washington, DC, May 15-18, 2005.

Botteman MF, Ozminkowski RJ, Wang S, Pashos CL, Foley DJ, Schaefer K. Cost effectiveness of longer-term treatment with eszopiclone 3mg in adults with primary insomnia. International Society for Pharmacoeconomics and Outcomes Research, 10th Annual International Meeting, Washington, DC, May 15-18, 2005.

Pashos CL, Lee JM, Botteman MF, Nicklasson L, Cobden D. Needlestick injury in acute care nurses caring for patients with diabetes mellitus: A retrospective study. International Society for Pharmacoeconomics and Outcomes Research, 10th Annual International Meeting, Washington, DC, May 15-18, 2005.

back to top

2004

Lee WC, Arcona S, Hoffmann M, Wang Q, Stephens J, Pashos CL. Cost associated with persistency among patients with partial seizure disorder switching to oxcarbazepine monotherapy. International Society for Pharmacoeconomics and Outcomes Research, 7th Annual European Congress, Hamburg, Germany, October 24-26, 2004.

Lee WC, Arcona S, Hoffmann M, Wang Q, Stephens J, Pashos CL. Effect of comorbidities on medical care use and cost among patients with partial seizure disorder. International Society for Pharmacoeconomics and Outcomes Research, 7th Annual European Congress, Hamburg, Germany, October 24-26, 2004.

Smith M, Lee WC, Krupski T, Brandman J, Wang Q, Botteman M, Pashos CL, Litwin M. Association between androgen deprivation therapy and fracture risk: A population-based cohort study in men with non-metastatic prostate cancer. American Society of Clinical Oncology, Annual Meeting, New Orleans, LA, June 5-8, 2004.

Krupski T, Smith M, Lee WC, Pashos C, Brandman J, Wang Q, Botteman M, Litwin M. Profile of men with prostate cancer on androgen deprivation therapy at greatest risk of bone complications. American Society of Clinical Oncology, Annual Meeting, New Orleans, LA, June 5-8, 2004.

Lee WC, Tran KT, Stephens JM, Dirani RG, Pashos CL. Adherence to oral diabetic drug regimen by racial group in the Texas Medicaid population. American Diabetes Association, 64th Annual Scientific Sessions, Orange County Convention Center, Orlando, FL, June 4-8, 2004.

Grad O, Davis J, Vichare R, Mucha L, Pashos C, Fastenau J, McKenzie RS, Piech CT. Dosing and Outcomes Study of Erythropoiesis-stimulating Therapies - D.O.S.E. Multinational Association of Supportive Care in Cancer, Annual Meeting, New Orleans, LA, June 2004.

Lee WC, Pashos CL. Using the difference in difference method to understand outcomes in prostate cancer. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.

Chavez YE, Lee WC, Botteman MF, Pashos CL. Cost-effectiveness of diagnostic, staging and treatment options for melanoma. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.

Lee WC, Stephens JM, Tran KT, Wang Q, Dirani RG, Pashos CL. The economic burden of type 2 diabetes management by ethnic group in the Texas Medicaid population. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.

Edwards N, Rupnow M, Pashos CL, Botteman MF, Locklear J, Diamond R. Cost-effectiveness evaluation of long-acting risperidone injection. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.

Tran KT, Stephens JM, Gold KF, Kimura A, Pashos CL, Muenzer J. Development and pilot testing of the Hunter Syndrome – Functional Outcomes for Clinical Understanding Scale: An instrument to assess functional health in Hunter Syndrome. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.

Tran KT, Gold KF, Stephens JM, Kimura A, Pashos CL, Muenzer J. Validation of the Hunter Syndrome – Functional Outcomes for Clinical Understanding Scale. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.

Lee WC, Barlas S, Gold KF, Duong P, Madoo L, Reddy P, Pashos CL. Anticipated pain prior to surgery compared to actual pain in patients undergoing outpatient arthroscopic knee procedures. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.

Botteman MF, Lowe FC, Naslund M, Sollano J, Pashos CL, Litwin M. A cost comparison analysis of two clinically uroselective alpha blockers in the treatment of benign prostatic hyperplasia. International Society for Pharmacoeconomics and Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.

Krupski TL, Smith M, Lee WC, Pashos C, Brandman J, Wang Q, Botteman M, Litwin MS. Fracture risk in men with prostate cancer on androgen deprivation therapy. American Urological Association, 99th Annual Meeting, San Francisco, CA, May 8-13, 2004.

Niren N, Grad O, Sung JC, Law A, Shah NP, Wang Q. Impact of atopic dermatitis treatment on quality of life – Results from the findings in atopic children with eczema study. American Academy of Dermatology, Annual Meeting, Washington, DC, February 6-11, 2004.